NICM
INSM icon

Neo Ivy Capital Management’s Insmed INSM Stock Holding History

Neo Ivy Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,688
Closed -$1.4M – 436
2025
Q3 		$1.4M Sell
9,688
-7,568
-44% -$927K 0.34% 112
2025
Q2 		$1.74M Buy
17,256
+12,804
+288% +$979K 0.55% 64
2025
Q1 		$340K Buy
+4,452
New +$341K 0.11% 210
2024
Q3 		– Sell
-18,436
Closed -$1.24M – 329
2024
Q2 		$1.24M Buy
+18,436
New +$715K 0.24% 133
2022
Q4 		$116K Sell
5,790
-2,841
-33% -$54.9K 0.08% 255
2022
Q3 		$186K Buy
8,631
+6,810
+374% +$163K 0.49% 68
2022
Q2 		$35K Sell
1,821
-2,205
-55% -$46.2K 0.09% 266
2022
Q1 		$94K Buy
4,026
+3,349
+495% +$77.8K 0.08% 309
2021
Q4 		$18K Buy
677
+221
+48% +$6.32K 0.03% 364
2021
Q3 		$13K Sell
456
-1,211
-73% -$31.8K 0.01% 411
2021
Q2 		$47K Buy
+1,667
New +$49.5K 0.05% 326
2020
Q3 		– Sell
-456
Closed -$13K – 534
2020
Q2 		$13K Buy
+456
New +$10.8K 0.01% 411

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Neo Ivy Capital Management's INSM Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 9,688 shares — an estimated $1.4M sold.

Neo Ivy Capital Management first reported a position in INSM in Q2 2020 and held it in 12 quarters. The position peaked at $1.74M in Q2 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 9,688 Insmed shares in Q4 2025, an estimated $1.4M.
  • Neo Ivy Capital Management first reported a position in Insmed in Q2 2020 and held it in 12 quarters.
  • Neo Ivy Capital Management's Insmed position peaked at $1.74M in Q2 2025.
  • 678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.